Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Hemab Therapeutics Holdings, Inc.

NASDAQ: COAG · Life Sciences · 3 alerts · CIK 2114044

Share price
$39.06Close, Nov 16
Market cap
$1.83B
Shares outstanding
46.73MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Hemab Therapeutics Holdings, Inc. filings on SEC EDGAR ↗

4:03 PM ET 8-K
Executive Compensation

Hemab Therapeutics Holdings Executive Compensation

Hemab Therapeutics Holdings, Inc. has appointed Keli Walbert to its Board of Directors and Audit Committee, effective September 24, 2026. Ms. Walbert will receive an annual cash retainer of $40,000 for board service plus $10,000 for committee service, along with an initial grant of options to purchase 36,000 shares of common stock vesting over three years. This appointment fills a Class I director seat with a term expiring at the 2027 annual meeting.

Counterparty
Keli Walbert

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.